Introduction
Multiple myeloma is a relatively common cause of hypercalcaemia in the elderly and most clinicians would attempt to exclude this possibility by screening serum and urine for abnormal monoclonal immunoglobulin secretion. Occasionally diagnosis is complicated by myeloma cells not secreting monoclonal immunoglobulin in serum or urine. It has been recognized that this so called non-secretory myeloma can cause hypercalcaemia.' 2 Radiographs of the skeleton have, however, always previously shown the typical lytic lesions of multiple myeloma in these circumstances.
We report a case of severe hypercalcaemia associated with a non-secretory myeloma in which the only radiological abnormality was a severe osteopenia. Although multiple myeloma was considered, the absence of serum markers and lytic lesions on radiographs caused the diagnosis to be missed in life and this potentially treatable condition was only discovered at post-mortem.
Case report
A 71 year old retired male marine engineer presented with a 3-month history of increasing confusion, unsteadiness and constipation. In the 12 months prior to admission he had four episodes of cystitis and a solitary episode of painless haematuria. He had been treated for pulmonary tuberculosis 35 years previously and for many years had suffered from chronic airways limitation which had caused his early retirement from work.
On examination he was thin, dehydrated, extremely confused, disorientated and agitated. General examination was otherwise normal. Rectal examination revealed a large hard right lobe of the prostate gland which felt neoplastic. Initial investigations showed haemoglobin 14.0 g/l, ESR 69mm/h, blood glucose, serum sodium and potassium were normal, blood urea 25.5 mmol/l, creatinine 225 jumol/l, plasma calcium 3.82 mmol/l (normal range 2.20-2.70 mmol/l), plasma phosphate 0.97 mmol/l (normal range 0.80-1.4 mmol/l), alkaline phosphatase 19 U/l, albumin 36 g/l and globulins 41 g/l. Serum immunoelectrophoresis on two occasions showed no abnormal monoclonal band, serum immunoglobulin levels were, IgG 10.36g/l (normal range 5.00-14.00g/l), IgA 2.55g/l (normal range 1.00-4.00g/l), IgM 0.90g/l (normal range 0.50-2.00g/l) and when repeated were again within normal limits. No light chains were detected by immunoelectrophoresis of the urine. Serum parathyroid hormone levels were 65 pmol/l and 35 pmol/l (reference range 29-85 pmol/l), plasma calcium levels taken simultaneously were 3.82mmol/l and 3.05mmol/l respectively.
A chest X-ray showed extensive pulmonary calcification caused by healed tuberculous lesions but no other abnormality. Radiographs of skull, thoraco-lumbar spine, pelvis, wrists and fingers showed a diffuse osteopenia suggestive of severe osteoporosis. A technetium-99m isotope bone scan showed no evidence of increased uptake. Technetium-pertechnolate subtraction scan of the parathyroid glands showed no abnormal uptake. An Diffuse osteopenia has been described in secretory multiple myeloma but rarely in the nonsecretory variety. A review of clinically documented cases of non-secretory multiple myeloma found 33 such subjects and described a further 2 cases;9 31 of these had evidence of lytic lesions on skeletal radiographs and only 4 cases were found with diffuse osteopenia alone; however none of these also had hypercalcaemia.
The presence of hypercalcaemia in association with non-secretory multiple myeloma in the absence of lytic lesions in bone is not surprising, and is explained by the way in which multiple myeloma causes bone resorption. It seems to be caused by the stimulation of osteoclasts by osteoclast activating factor,10 a group of monokine and lymphokine-like substances which are secreted by the malignant plasma cell 11 independently of immunoglobulin manufacture and act generally on the skeleton and not just locally at the site of bone destruction by myelomatous deposits.
This case describes a previously unreported association of hypercalcaemia secondary to nonsecretory multiple myeloma with diffuse osteopenia but more importantly emphasizes the need to consider non-secretory multiple myeloma in the differential diagnosis of hypercalcaemia in the elderly. We would particularly emphasize the need for bone marrow examination if the cause of the hypercalcaemia seems obscure, otherwise a potentially treatable condition may be missed.
